Press Releases

November 10, 2016, Redwood City, Calif – (Business Wire) – Data from Sonata Technology Platform Featured in Presentations at AAGL Global Congress in Orlando 

October 19, 2016, Redwood City, Calif – (Business Wire) – Sonata Technology Platform Featured in Presentations at Upcoming Congress of the German Society of Obstetrics and Gynecology (DGGG)

October 18, 2016, Redwood City, Calif – (Business Wire) – Gynesonics Announces Early Completion of Enrollment in the SONATA FDA Clinical Trial for Incision Free Treatment of Symptomatic Uterine Fibroids

May 5, 2016, Redwood City, Calif – (Business Wire) – Gynesonics Names Jiayu Chen, PhD, Vice President, Engineering and Advanced Technologies

February 25, 2016, Redwood City, Calif – (Business Wire) – Gynesonics Names Taraneh G. Farazi Vice President, Clinical Affairs

November 17, 2015, Redwood City, Calif – (Business Wire) – Gynesonics Completes $46 Million Equity Financing

November 12, 2015, Redwood City, Calif – (Business Wire) – Gynesonics Technology Featured in Five Presentations at 2015 American Association of Gynecologic Laparoscopists Global Congress

August 4, 2015, Redwood City, Calif – (Business Wire) – Gynesonics Announces New CPT Code Established For Sonata™ System

July 22, 2015, Redwood City, Calif – (Business Wire) – Gynesonics Raises $43 Million in Equity Financing

June 30, 2015, Redwood City, Calif – (Business Wire) – Gynesonics’ Sonata™ System Winner of 2015 Medical Design Excellence Award

December 9, 2014, Redwood City, Calif – (Business Wire) – FAST-EU Trial 6 Month Results Published in Gynecological Surgery; 12 Month Results presented at 43rd Annual AAGL Meeting.

October 21, 2014, Redwood City, Calif – (Business Wire) –FDA Grants Approval To Commence SONATA Pivotal IDE Clinical Trial.

October 9, 2014, Redwood City, Calif – (Business Wire) –Gynesonics named to FierceMedicalDevices ‘2014 Fierce 15’ 

August 7, 2014, Redwood City, Calif – (Business Wire) – Gynesonics names Richard P. Lanigan as Vice
President, Global Commercialization.

June 24, 2014, Redwood City, Calif – (Business Wire) – Gynesonics announces first patient successfully
treated with newly designed VizAbate System

June 12, 2014, Redwood City, Calif – (Business Wire) – Gynesonics Inc. announced today that it has received CE Mark approval for its next generation VizAblate® System enabling use throughout the European Union.

April 22, 2014, Redwood City, Calif – (Business Wire) – Gynesonics Inc., a women’s healthcare company focused on minimally invasive solutions for symptomatic uterine fibroids announces the appointment of Christopher M. Owens to president and Chief Executive Officer.

February 22, 2013, Redwood City, Calif – (Business Wire) – Gynesonics, Inc., a women’s healthcare company focused on minimally invasive solutions for symptomatic uterine fibroids, announced today a Series D financing led by HBM Partners based in Switzerland.